HRMY vs. GDE
HRMY (Harmony Biosciences Holdings, Inc.) is a stock, while GDE (WisdomTree Efficient Gold Plus Equity Strategy Fund) is Gold fund actively managed by WisdomTree. Over the past 3 years, HRMY returned 1.21%/yr vs 38.84%/yr for GDE. Their 0.17 correlation means their historical movements had little consistent relationship.
Performance
HRMY vs. GDE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, HRMY achieves a -5.83% return, which is significantly lower than GDE's -0.84% return.
HRMY
- 1D
- -1.73%
- 1M
- -5.42%
- 6M
- -3.50%
- YTD
- -5.83%
- 1Y
- 2.44%
- 3Y*
- 1.21%
- 5Y*
- 6.14%
- 10Y*
- —
- ALL TIME*
- -2.10%
GDE
- 1D
- -0.71%
- 1M
- -1.55%
- 6M
- -11.26%
- YTD
- -0.84%
- 1Y
- 33.38%
- 3Y*
- 38.84%
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- 29.08%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $4.75M | $8.80M | $9.79M | |
| $30.21M | $30.03M | $28.08M |
HRMY vs. GDE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
HRMY Harmony Biosciences Holdings, Inc. | -5.83% | 8.75% | 6.53% | -41.38% | 15.47% |
GDE WisdomTree Efficient Gold Plus Equity Strategy Fund | -0.84% | 73.76% | 44.79% | 33.85% | -8.58% |
Correlation
The correlation between HRMY and GDE is 0.07, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.07 |
Correlation (3Y) Balances recent behavior with more history. | 0.14 |
Correlation (All Time) Calculated using the full available price history since Mar 17, 2022 | 0.17 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
HRMY vs. GDE — Risk / Return Rank
HRMY
GDE
HRMY vs. GDE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Harmony Biosciences Holdings, Inc. (HRMY) and WisdomTree Efficient Gold Plus Equity Strategy Fund (GDE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| HRMY | GDE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.08 | ||
| Sortino ratioReturn per unit of downside risk | -1.18 | ||
| Omega ratioGain probability vs. loss probability | 1.04 | 1.21 | -0.16 |
| Calmar ratioReturn relative to maximum drawdown | 0.01 | 1.49 | -1.48 |
| Martin ratioReturn relative to average drawdown | 0.01 | 3.27 | -3.26 |
Loading charts...
Drawdowns
HRMY vs. GDE - Drawdown Comparison
The maximum HRMY drawdown since its inception was -68.48%, which is greater than GDE's maximum drawdown of -32.01%. Use the drawdown chart below to compare losses from any high point for HRMY and GDE.
Loading charts...
Drawdown Indicators
| HRMY | GDE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -68.48% | -32.01% | -36.47% |
Max Drawdown (1Y)Largest decline over 1 year | -34.49% | -22.66% | -11.83% |
Max Drawdown (3Y)Largest decline over 3 years | -50.81% | -22.66% | -28.15% |
Max Drawdown (5Y)Largest decline over 5 years | -68.48% | — | — |
Current DrawdownCurrent decline from peak | -42.14% | -19.77% | -22.37% |
Average DrawdownAverage peak-to-trough decline | -35.42% | -8.25% | -27.17% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 19.24% | 10.30% | +8.94% |
Volatility
HRMY vs. GDE - Volatility Comparison
Harmony Biosciences Holdings, Inc. (HRMY) has a higher volatility of 14.79% compared to WisdomTree Efficient Gold Plus Equity Strategy Fund (GDE) at 7.99%. This indicates that HRMY's price experiences larger fluctuations and is considered to be riskier than GDE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| HRMY | GDE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 14.79% | 7.99% | +6.80% |
Volatility (6M)Calculated over the trailing 6-month period | 32.46% | 26.11% | +6.35% |
Volatility (1Y)Calculated over the trailing 1-year period | 43.31% | 31.06% | +12.25% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 50.15% | 27.12% | +23.03% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 52.28% | 27.12% | +25.16% |
Dividends
HRMY vs. GDE - Dividend Comparison
HRMY has not paid dividends to shareholders, while GDE's dividend yield for the trailing twelve months is around 4.36%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
GDE WisdomTree Efficient Gold Plus Equity Strategy Fund | 4.36% | 4.32% | 7.14% | 2.22% | 0.81% |
HRMY Harmony Biosciences Holdings, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
HRMY and GDE have a correlation of 0.07, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
HRMY has higher volatility (14.79%) compared to GDE (7.99%). In terms of maximum drawdown, HRMY dropped -68.48% vs GDE's -32.01%.
GDE currently has the higher Sharpe Ratio (1.09 vs 0.00), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for HRMY and GDE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer